Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nella C. Delva"'
Autor:
Jennifer Emmel, Kim E. Creek, Phillip Buckhaults, Carolyn E. Banister, Fadi F. Abboodi, Lucia Pirisi, Ariana Renrick, Nella C. Delva
Publikováno v:
Genome Instability & Disease. 2:71-91
High-risk human papillomaviruses (HPV) cause 5% of all human cancers and are primary etiologic agents of cervical, anal, and oropharyngeal cancer. HPV infection is necessary, but not sufficient per se to produce cancer: additional changes must occur
Autor:
Nella C. Delva, Gregg D. Stanwood
Publikováno v:
Exp Biol Med (Maywood)
Major depressive disorder (MDD or depression) is a debilitating neuropsychiatric syndrome with genetic, epigenetic, and environmental contributions. Depression is one of the largest contributors to chronic disease burden; it affects more than one in
Autor:
Michael L. Langsen, Robert W. Engelman, Michael L. Doligalski, Darpan N. Pandya, Mark L. McLaughlin, Narges K. Tafreshi, David L. Morse, HyunJoo Kil, Christopher J. Tichacek, Eduardo G. Moros, Thaddeus J. Wadas, Kenneth L. Gage, John A. Vallas, David Boulware, Nella C. Delva, Mikalai M. Budzevich
Publikováno v:
ACS Pharmacol Transl Sci
[Image: see text] Lipophilicity is explored in the biodistribution (BD), pharmacokinetics (PK), radiation dosimetry (RD), and toxicity of an internally administered targeted alpha-particle therapy (TAT) under development for the treatment of metastat
Autor:
Narges K. Tafreshi, Nancy D. Kock, Ghassan El-Haddad, Thaddeus J. Wadas, Jane L. Messina, Adam Weaver, Christopher J. Tichacek, Nikunj Bhatt, Michael L. Doligalski, Darpan N. Pandya, David L. Morse, HyunJoo Kil, David Boulware, Nikhil I. Khushalani, William R. Gibbons, Pierre L. Triozzi, Eduardo G. Moros, Epifanio Ruiz, Nella C. Delva, Mikalai M. Budzevich, Mark L. McLaughlin
New effective therapies are greatly needed for metastatic uveal melanoma, which has a very poor prognosis with a median survival of less than 1 y. The melanocortin 1 receptor (MC1R) is expressed in 94% of uveal melanoma metastases, and a MC1R-specifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::360fb3c67f26a8360b8de9500243ddfa
https://europepmc.org/articles/PMC6681690/
https://europepmc.org/articles/PMC6681690/
Autor:
HyunJoo Kil, David L. Morse, Nikunj Bhatt, Mikalai M. Budzevich, Nella C. Delva, Christopher J. Tichacek, Narges K. Tafreshi, Epifanio Ruiz, Mark L. McLaughlin, Michael L. Doligalski, Darpan N. Pandya, Thaddeus J. Wadas
Publikováno v:
Cancer Research. 77:5198-5198
New effective therapies are greatly needed for uveal melanoma, the most common ocular malignancy, which has a very poor prognosis with a median survival of less than one year when metastatic disease develops. The melanocortin 1 receptor (MC1R) is exp
Autor:
Amer A. Beg, Michael L. Doligalski, David L. Morse, Hong Zheng, Veronica Estrella, Allison S. Cohen, Narges K. Tafreshi, Jonathan Nguyen, Mark L. McLaughlin, Nella C. Delva
Publikováno v:
Cancer Research. 77:1709-1709
Lung cancer is the leading cause of cancer deaths worldwide. Many lung cancer patients are diagnosed with advanced disease. These patients have a low 5-year survival rate and limited treatment options. Novel therapies, which target biomarkers that ar
Autor:
Delva, Nella C, Stanwood, Gregg D
Publikováno v:
Experimental Biology & Medicine; May2021, Vol. 246 Issue 9, p1084-1093, 10p